abaloparatide
Selected indexed studies
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial. (JAMA, 2016) [PMID:27533157]
- Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis. (J Bone Miner Metab, 2025) [PMID:39009890]
- Abaloparatide. (Clin Cases Miner Bone Metab, 2016) [PMID:27920805]
_Worker-drafted node — pending editorial review._
Connections
abaloparatide is a side effect of
Sources
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial. (2016) pubmed
- Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis. (2025) pubmed
- Abaloparatide. (2016) pubmed
- Abaloparatide: A new pharmacological option for osteoporosis. (2019) pubmed
- PMID:39913647 (2024) pubmed
- Abaloparatide: A review of preclinical and clinical studies. (2021) pubmed
- Abaloparatide and the Spine: A Narrative Review. (2020) pubmed
- Abaloparatide. (2026) pubmed
- The clinician's guide to prevention and treatment of osteoporosis. (2022) pubmed
- Abaloparatide for the treatment of postmenopausal osteoporosis. (2018) pubmed